Related Experiment Video
Updated: Feb 24, 2026
Multi-electrode Array Recordings of Human Epileptic Postoperative Cortical Tissue
Published on: October 26, 2014
MicroRNA and mesial temporal lobe epilepsy with hippocampal sclerosis: Whole miRNome profiling of human hippocampus
Petra Bencurova1,2,3, Jiri Baloun1,2,3, Katerina Musilova1,3
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Objective:
Mesial temporal lobe epilepsy (mTLE) is a severe neurological disorder characterized by recurrent seizures. mTLE is frequently accompanied by neurodegeneration in the hippocampus resulting in hippocampal sclerosis (HS), the most common morphological correlate of drug resistance in mTLE patients. Incomplete knowledge of pathological changes in mTLE+HS complicates its therapy. The pathological mechanism underlying mTLE+HS may involve abnormal gene expression regulation, including posttranscriptional networks involving microRNAs (miRNAs). miRNA expression deregulation has been reported in various disorders, including epilepsy. However, the miRNA profile of mTLE+HS is not completely known and needs to be addressed.
Methods:
Here, we have focused on hippocampal miRNA profiling in 33 mTLE+HS patients and nine postmortem controls to reveal abnormally expressed miRNAs. In this study, we significantly reduced technology-related bias (the most common source of false positivity in miRNA profiling data) by combining two different miRNA profiling methods, namely next generation sequencing and miRNA-specific quantitative real-time polymerase chain reaction.
Results:
These methods combined have identified and validated 20 miRNAs with altered expression in the human epileptic hippocampus; 19 miRNAs were up-regulated and one down-regulated in mTLE+HS patients. Nine of these miRNAs have not been previously associated with epilepsy, and 19 aberrantly expressed miRNAs potentially regulate the targets and pathways linked with epilepsy (such as potassium channels, γ-aminobutyric acid, neurotrophin signaling, and axon guidance).
Significance:
This study extends current knowledge of miRNA-mediated gene expression regulation in mTLE+HS by identifying miRNAs with altered expression in mTLE+HS, including nine novel abnormally expressed miRNAs and their putative targets. These observations further encourage the potential of microRNA-based biomarkers or therapies.
Insights
Researchers identified 20 microRNAs (miRNAs) with altered expression in the hippocampus of mesial temporal lobe epilepsy (mTLE) patients with hippocampal sclerosis (HS). This study reveals novel miRNA profiles in mTLE+HS, suggesting potential for new biomarkers and therapies.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Mesial temporal lobe epilepsy (mTLE) is a severe neurological disorder often linked to hippocampal sclerosis (HS), a condition complicating treatment due to incomplete understanding of its pathology.
- MicroRNAs (miRNAs) are implicated in gene expression regulation and have been found to be deregulated in various diseases, including epilepsy.
- The specific miRNA profile in mTLE with hippocampal sclerosis (mTLE+HS) remains largely unknown, hindering therapeutic advancements.
Purpose of the Study:
- To investigate the hippocampal miRNA expression profile in patients with mTLE+HS.
- To identify specific miRNAs that are abnormally expressed in the epileptic hippocampus.
- To explore the potential role of these miRNAs in the pathogenesis of mTLE+HS and their implications for future diagnostics and therapeutics.
Main Methods:
- Hippocampal tissue samples from 33 mTLE+HS patients and nine postmortem controls were analyzed.
- Dual miRNA profiling methods, next-generation sequencing and miRNA-specific quantitative real-time polymerase chain reaction, were employed to minimize technology-related bias.
- Combined methodologies ensured robust identification and validation of differentially expressed miRNAs.
Main Results:
- A total of 20 miRNAs exhibited altered expression in the epileptic hippocampus of mTLE+HS patients.
- Of these, 19 miRNAs were significantly upregulated, and one was downregulated.
- Nine of the identified miRNAs have no prior association with epilepsy, and 19 potentially regulate key epilepsy-related pathways.
Conclusions:
- This study significantly expands the understanding of miRNA-mediated gene regulation in mTLE+HS.
- Novel abnormally expressed miRNAs and their putative targets in mTLE+HS have been identified.
- The findings support the potential utility of miRNAs as diagnostic biomarkers or therapeutic targets for mTLE+HS.
